London, UK, May 2024 -- SpatialX Ltd is excited to announce results from its collaboration with UPMC that will be presented by Nuha Shaker, MD, at the Association of Pathology Informatics conference in May. Attendees are encouraged to join her talk on the innovative application of SpatialX's platform in AI pathology.

SpatialX announces the results from an advanced AI model for eosinophil detection in colon cancer. These groundbreaking results, part of a collaboration with pathologists at UPMC, will be presented during Dr. Shaker's session.

Dr. Shaker will be discussing her paper titled "AI-powered Mapping of Eosinophils Distribution in Colorectal Cancer," which highlights the importance of eosinophils analysis in cancer diagnostics and treatment.

Eosinophils, play a significant role in the body's immune response and have been found to influence the progression and prognosis of colorectal cancer. Accurate detection and mapping of eosinophils within tumor tissues can provide valuable insights into the tumor microenvironment (TME). Understanding the TME is crucial as it impacts tumor growth, metastasis, and response to therapies.

SpatialX’s AI model leverages advanced deep learning algorithms to analyze whole-slide images, accurately identifying and mapping eosinophil distribution within the colon cancer tissue. This detailed analysis enables pathologists and oncologists to gain a deeper understanding of the TME, facilitating more precise diagnostics and personalized treatment plans.

"The integration of AI in pathology is revolutionizing how we approach cancer diagnostics," said Dr. Shaker. "SpatialX's AI-powered model not only enhances the detection accuracy of eosinophils but also provides a scalable way of deploying these models so we can get critical insights into the tumor microenvironment. This has the potential to impact patient outcomes significantly."

The presentation will delve into the technical aspects of the AI model, its development in collaboration with UPMC, and the implications of these findings for the future of cancer diagnostics. Attendees will gain insights into the transformative potential of AI in pathology and how SpatialX is leading the way in harnessing this technology to fight cancer.

Don't miss this opportunity to learn about the cutting-edge advancements in AI pathology and how SpatialX is at the forefront of this medical revolution.